Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01058707
Title Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

Sapanisertib

Age Groups: adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Scottsdale Arizona United States Details
Los Angeles California United States Details
Miami Florida United States Details
Sarasota Florida United States Details
Indianapolis Indiana United States Details
Boston Massachusetts United States Details
Ann Arbor Michigan United States Details
Detroit Michigan United States Details
Buffalo New York United States Details
New York New York United States Details
Cleveland Ohio United States Details
Oklahoma City Oklahoma United States Details
Philadelphia Pennsylvania United States Details
Nashville Tennessee United States Details
Barcelona Spain Details
Valencia Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field